Sandu Pharmaceuticals logo

Sandu Pharmaceuticals

SANDUPHARMACEUTICALSLTD NSE

Key Fundamentals

MicrocapPharmaceuticalsHealthcare
Market Cap
₹36.60 Cr
Volatility
Moderate
P/E Ratio
20.7
EBITDA
₹2.90 Cr
Return on Equity
3.69%
Debt to Equity
0
Book Value
₹36.48
EPS
₹1.57
52W High
₹50.44
52W Low
₹30

Tapetide Score

Data-driven rating, 0–100. How it works →

Key Insights

Strengths

3
  • Company is almost debt free.
  • Stock is trading at 0.82 times its book value
  • Company's working capital requirements have reduced from 53.8 days to 42.0 days

Weaknesses

4
  • The company has delivered a poor sales growth of 3.54% over past five years.
  • Promoter holding is low: 37.8%
  • Company has a low return on equity of 3.85% over last 3 years.
  • Promoter holding has decreased over last 3 years: -14.6%

Growth Rate

Revenue Growth
-0.44% lower than 3Y
Net Income Growth
6.67% higher than 3Y
Cash Flow Change
25% lower than 3Y
ROE
2.5% lower than 3Y
ROCE
1.37% higher than 3Y
EBITDA Margin (Avg.)
8.21% higher than 3Y

Quarterly Results

Particulars Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales
17.66
16.61
17.43
15.6
17.05
17.7
18.37
14.07
16.7
17.62
18.76
16.85
16.39
Expenses
17.31
15.79
16.92
15
16.64
16.78
17.37
13.62
16.17
16.76
17.72
16.28
15.86
Operating Profit
0.35
0.82
0.51
0.6
0.41
0.92
1
0.45
0.53
0.86
1.04
0.57
0.53
OPM %
1.98%
4.94%
2.93%
3.85%
2.4%
5.2%
5.44%
3.2%
3.17%
4.88%
5.54%
3.38%
3.23%
Other Income
0
0.09
0.03
0.31
0.04
0.03
0.02
0.07
0.02
0.05
0.01
0.37
0.02
Interest
0.02
0.01
0.02
0.01
0.02
0.03
0.03
0.03
0.03
0.03
0.03
0.03
0.03
Depreciation
0.12
0.13
0.14
0.19
0.16
0.17
0.19
0.15
0.18
0.17
0.17
0.16
0.16
PBT
0.21
0.77
0.38
0.71
0.27
0.75
0.8
0.34
0.34
0.71
0.85
0.75
0.36
Tax %
47.62%
27.27%
44.74%
16.9%
40.74%
32%
30%
2.94%
35.29%
26.76%
-14.12%
93.33%
36.11%
Net Profit
0.11
0.55
0.21
0.59
0.17
0.5
0.56
0.33
0.22
0.52
0.98
0.04
0.23
EPS in Rs
0.11
0.57
0.22
0.61
0.18
0.52
0.58
0.34
0.23
0.54
1.01
0.04
0.24
Figures in ₹ Crores

Profit & Loss

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales
38.17
38.86
42.82
49.02
49.42
48.37
58.76
65.5
65.35
67.28
67.19
69.93
69.62
Expenses
35.74
35.97
40.97
46.55
47.33
46.92
56.6
62.62
62.86
64.98
64.43
66.93
66.62
Operating Profit
2.43
2.89
1.85
2.47
2.09
1.45
2.16
2.88
2.49
2.3
2.76
3
3
OPM %
6.37%
7.44%
4.32%
5.04%
4.23%
3%
3.68%
4.4%
3.81%
3.42%
4.11%
4.29%
4.31%
Other Income
0.14
0.12
0.56
0.12
0.57
0.45
0.19
0.08
0.33
0.42
0.17
0.44
0.45
Interest
1.37
1.64
1.49
1.23
1.01
0.43
0.11
0.11
0.08
0.06
0.1
0.11
0.12
Depreciation
0.57
0.69
0.87
0.6
0.64
0.55
0.56
0.53
0.52
0.58
0.67
0.68
0.66
PBT
0.63
0.68
0.05
0.76
1.01
0.92
1.68
2.32
2.22
2.08
2.16
2.65
2.67
Tax %
34.92%
22.06%
1000%
26.32%
34.65%
21.74%
35.12%
31.47%
31.08%
29.33%
28.24%
33.58%
—
Net Profit
0.41
0.54
-0.44
0.56
0.67
0.72
1.09
1.59
1.52
1.46
1.55
1.77
1.77
EPS in Rs
0.58
0.76
-0.62
0.79
0.95
1.02
1.38
1.8
1.57
1.51
1.6
1.83
1.83
Div. Payout %
0%
0%
0%
0%
0%
0%
36.33%
41.56%
0%
52.93%
49.86%
0%
—
Figures in ₹ Crores

Balance Sheet

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital
7.08
7.08
7.08
7.08
7.08
7.08
7.92
8.81
9.66
9.66
9.66
9.66
Reserves
11.06
11.6
20.33
21
21.71
22.16
25.57
27.66
29.58
30.93
32.36
34.01
Borrowings
12.47
11.39
10.56
9.42
6.17
1.25
0.02
0
0
0
0.06
0.11
Other Liabilities
10.91
11.33
8.46
7.03
8.67
10.92
13.45
12.81
14.92
11.83
13.64
12.09
Total Liabilities
41.52
41.4
46.43
44.53
43.63
41.41
46.96
49.28
54.16
52.42
55.72
55.87
Fixed Assets
8.36
7.81
17.49
17.57
17.04
16.6
16.17
16
16.62
17.88
18.15
18.12
CWIP
0
0
0
0
0
0
0
0.48
0.42
0
0
0.06
Investments
0.7
0.73
0.99
1.12
1.13
0.82
0.24
9.11
9.66
10.43
11.22
12.3
Other Assets
32.46
32.86
27.95
25.84
25.46
23.99
30.55
23.69
27.46
24.11
26.35
25.39
Total Assets
41.52
41.4
46.43
44.53
43.63
41.41
46.96
49.28
54.16
52.42
55.72
55.87
Figures in ₹ Crores

Cash Flow

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating
4.75
-1.43
4.91
1.23
3.74
6.2
7.59
0.95
0.22
0.76
0.95
6.12
Investing
-0.18
0.05
-0.59
-0.62
-0.1
-0.37
-5.58
-5.47
0.53
-1.31
-0.18
-0.57
Financing
-1.9
-2.06
-2.33
-1.89
-4.26
-5.36
1.3
0.93
0.58
-0.72
-0.46
-0.94
Net Cash Flow
2.67
-3.44
1.99
-1.28
-0.62
0.48
3.31
-3.59
1.33
-1.27
0.31
4.6
Free Cash Flow
4.43
-1.58
4.3
0.6
3.63
6.09
7.46
0.11
-0.85
-0.67
0.01
5.4
CFO/OP
201
-42
195
63
194
437
373
64
37
55
55
229
Figures in ₹ Crores

Ratios

Particulars Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days
62.73
67.16
54.13
49.81
35.45
35.32
33.23
22.23
26.75
26.42
25.86
28.24
Inventory Days
210
207
152
147
191
209
118
115
168
137
161
121
Days Payable
103
101
58.22
38.75
60.93
83.69
70.57
69.63
98.3
46.96
51.05
51.68
Cash Conversion Cycle
169
173
148
158
166
160
80.52
67.67
96.15
117
136
97.61
Working Capital Days
68.47
105
60.69
30.16
40.1
72.06
39.51
42.41
52.33
56.75
62.8
41.96
ROCE %
6.8%
7.75%
4.26%
5.14%
5.58%
4.13%
5.59%
6.94%
6.08%
5.36%
5.47%
6.43%

Insights

Beta

AI-extracted from concalls & annual reports · figures as reported, with sources

Log in to view Sandu Pharmaceuticals insights

63 extracted metrics + investor summaries across FY11–FY26.

Log in — free

Shareholding Pattern

DIIs0.01%Promot.37.79%Others25.19%Public37.02%As ofJun 2026

Documents

Frequently Asked Questions about Sandu Pharmaceuticals

What does Sandu Pharmaceuticals Ltd do?
Incorporated in 1985, Sandu Pharmaceuticals Ltd is a manufacturer of Ayurvedic Medicines.[1]
Where is Sandu Pharmaceuticals Ltd (524703) listed?
Sandu Pharmaceuticals Ltd trades as SANDUPHARMACEUTICALSLTD on the NSE and under code SANDUPHQ on the BSE.
Which sector does Sandu Pharmaceuticals Ltd belong to?
Sandu Pharmaceuticals Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
What is the market capitalisation of Sandu Pharmaceuticals Ltd?
Sandu Pharmaceuticals Ltd has a market capitalisation of ₹36.6 Cr, which places it in the Small Cap band.
What is the PE ratio of Sandu Pharmaceuticals Ltd?
Sandu Pharmaceuticals Ltd trades at a PE ratio of 20.70, on earnings per share of ₹1.57, against a book value of ₹36.48 per share.
What is the 52-week high and low of Sandu Pharmaceuticals Ltd?
Over the last 52 weeks Sandu Pharmaceuticals Ltd has traded between ₹30 and ₹50.44.
Does Sandu Pharmaceuticals Ltd pay dividends?
Sandu Pharmaceuticals Ltd has a dividend yield of 2.64%.
What is the Return on Equity (ROE) of Sandu Pharmaceuticals Ltd?
Sandu Pharmaceuticals Ltd reported a return on equity of 3.69%. Its debt-to-equity ratio is 0.00.

Company Information

Incorporated in 1985, Sandu Pharmaceuticals Ltd is a manufacturer of Ayurvedic Medicines.[1]

Website sandu.in
Face Value ₹ 10

For AI agents and developers

Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524703.md for Sandu Pharmaceuticals Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.

Append .md to any Tapetide URL for the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For live, structured queries instead of documents, use our MCP server.

Explore More

More in Healthcare → FII DII Data Stock Screener Nifty 50 Heatmap F&O Ban List